Klebsiella-focused Research-grade Drug Discovery Service

At the frontier of cutting-edge scientific advancements, Creative Biolabs is proud to be offering our comprehensive research-grade drug discovery service designed specifically for Klebsiella infection research. Our objective is to empower researchers by providing them with state-of-the-art research tools and technological know-how.

Klebsiella Infection Introduction

• Klebsiella is a common gram-negative bacteria found in soil and water, among other environments. Moreover, it is present in the human intestines, but there are generally no health concerns there. On the other hand, this bacterium causes a variety of diseases, including meningitis, wound or infection at the surgical site, pneumonia, and bloodstream infections.
• Klebsiella infections are more common in healthcare settings, especially among those who have weakened immune systems or have been hospitalized for a long time. This is because the bacterium can spread through direct contact between people or, less frequently, through environmental contamination. Ongoing research aims to better understand Klebsiella and how to manage drug-resistant strains.
• The symptoms of a Klebsiella infection depend on the area of the body that's affected but can include fever, chills, flu-like symptoms, and in severe cases, shortness of breath and chest pain.
• Pneumonia triggered by Klebsiella can result in lung abscess (a pus-filled cavity in the lung) and inflammation around the lungs. In bloodstream infections, the bacteria can quickly spread to other parts of the body.

Our Offerings

Fig. 1 Workflow of the quantitative proteomic analysis of differentially expressed proteins in Klebsiella.¹

The rise in multidrug-resistant Klebsiella infections poses significant global health challenges. At Creative Biolabs, our drug discovery service specializes in Klebsiella research, aiming to pave the way for the formulation of research-grade therapeutic drugs. Please contact us to advance your Klebsiella infection research together.

Reference:

1. Hao, Ling, et al. "Molecular Characteristics and Quantitative Proteomic Analysis of Klebsiella pneumoniae Strains with Carbapenem and Colistin Resistance." Antibiotics 11.10 (2022): 1341.

• Pseudomonas aeruginosa Infection
• Streptococcus pneumoniae Infection
• Staphylococcus aureus Infection
• Escherichia coli Infection